Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Ion Beam Applications SA IBA ( (GB:0GZK) ) has provided an update.
IBA has announced the departure of Soumya Chandramouli as Chief Financial Officer, effective January 31, 2025, after a 21-year tenure. Henri de Romrée, Deputy CEO, will oversee the financial operations until a successor is appointed. This transition is expected to be smooth, with Henri’s extensive experience ensuring stability. The announcement highlights Soumya’s significant contributions to the company’s strategic direction and financial success, while expressing gratitude for her service and optimism for her future endeavors.
More about Ion Beam Applications SA IBA
IBA (Ion Beam Applications S.A.) is a global leader in particle accelerator technology, focusing on proton therapy solutions, which are considered the most advanced form of radiation therapy. The company also plays a significant role in industrial sterilization, radiopharmaceuticals, and dosimetry. Headquartered in Louvain-la-Neuve, Belgium, IBA employs around 2,000 people worldwide and is listed on EURONEXT.
YTD Price Performance: -0.15%
Average Trading Volume: 1,419
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €395M
Find detailed analytics on 0GZK stock on TipRanks’ Stock Analysis page.
